06855.HK
Ascentage Pharma Group International
HKSE · Healthcare · Biotechnology · CN
HKD 35.00
+1.74%Next report
Analyst consensus
- Next report date
- Mar 31, 2027
- EPS estimate
- -HKD 0.64
- Revenue estimate
- HKD 381.9M
Latest reported
- Last report date
- Aug 18, 2026
- EPS actual
- -HKD 2.53
- EPS estimate
- -HKD 0.43
- Revenue actual
- HKD 348.8M
- Revenue estimate
- HKD 422.4M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -483.7%
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 31, 2027